Vasogen absorbed; plants manufacturing vaccines;

> Beleaguered Vasogen, which in April suffered a clinical trial delay for its heart failure therapy Celacade that led to a massive layoff, is being acquired by IntelliPharmaCeutics. Release

> Tobacco plants are being used as vaccine manufacturing facilities to produce a drug that prevents norovirus, the dreaded cruise ship illness. The vaccine is one of several that researchers are targeting as they look for quick and efficient ways to bring vaccines to market. Article

> Versartis's lead drug candidate, a recombinant fusion protein for treating type 2 diabetes, will be produced in partnership with SynCo Bio Partners, a Netherlands-based contract manufacturer. The CMO will develop production process and optimize manufacturing for cGMP production. Release

> Nutritional supplements maker Herbalife is buying manufacturing assets from Micelle Laboratories, a contract manufacturer of supplements in powder, liquid, tablet and capsule forms. Article

>Such techniques as near infrared, Fourier transform infrared, mass spectroscopy and focused beam reflectance measurement are helping improve the control of pharmaceutical blending, granulation, drying and coating operations. Article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.